These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34029643)

  • 61. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
    Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
    Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
    Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
    Ann Surg Oncol; 2022 Oct; 29(11):6962-6975. PubMed ID: 35723792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.
    Yang W; Hu R; Li GC; Zhou ML; Wang Y; Shen LJ; Liang LP; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20170594. PubMed ID: 29927628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
    Gwak HK; Kim WC; Kim HJ; Park JH
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
    Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
    Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
    Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study.
    Zhou ML; Li GC; Yang W; Deng WJ; Hu R; Wang Y; Long ZW; Liu XW; Wang YN; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20180276. PubMed ID: 29906235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
    Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.
    An HJ; Yu CS; Yun SC; Kang BW; Hong YS; Lee JL; Ryu MH; Chang HM; Park JH; Kim JH; Kang YK; Kim JC; Kim TW
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):73-80. PubMed ID: 22300562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oncological Outcomes of Transanal Endoscopic Microsurgery Plus Adjuvant Chemoradiotherapy for Patients with High-Risk T1 and T2 Rectal Cancer.
    Xu K; Liu Y; Yu P; Shang W; Zhang Y; Jiao M; Cui Z; Xia L; Chen J
    J Laparoendosc Adv Surg Tech A; 2021 Sep; 31(9):1006-1013. PubMed ID: 33026943
    [No Abstract]   [Full Text] [Related]  

  • 77. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.
    Hasebe T; Konishi M; Iwasaki M; Endoh Y; Nakagohri T; Takahashi S; Kinoshita T; Ochiai A
    Hum Pathol; 2005 Jun; 36(6):655-64. PubMed ID: 16021572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.